A nurse in a long-term care facility is collecting data from a client who has a new prescription for glyburide.
The client reports feeling anxious and having profuse sweating.
Which of the following findings should the nurse expect?

Choice A rationale:

Montelukast does not improve peripheral vasodilation. It is a leukotriene receptor antagonist used to reduce inflammation in the airways.

Choice B rationale:

Montelukast does not increase the WBC count. It works by reducing inflammation in the airways, not by affecting the immune system.

Choice C rationale:

Montelukast does not neutralize gastric acid. It is not an antacid or proton pump inhibitor, it is used to reduce inflammation in the airways.

Choice D rationale:

Montelukast reduces bronchial inflammation. It helps to prevent asthma attacks and exercise-induced bronchoconstriction by reducing inflammation in the airways.

Choice A rationale:

Atenolol is a beta-blocker used to treat high blood pressure and heart-related conditions. It’s not used in the treatment of alcohol use disorder.

Choice B rationale:

Lorazepam is a benzodiazepine used to treat anxiety disorders. It can be used in the acute management of alcohol withdrawal, but it doesn’t assist in maintaining abstinence.

Choice C rationale:

Disulfiram is a medication used to support the treatment of chronic alcoholism by producing an acute sensitivity to ethanol (drinking alcohol) If alcohol is consumed when a patient has received disulfiram treatment, they suffer from a disulfiram-alcohol reaction, which can include symptoms like flushing, nausea, vomiting, and headaches. This aversive effect aids in discouraging the consumption of alcohol.

Choice D rationale:

Carbamazepine is an anticonvulsant and mood stabilizer medication used primarily in the treatment of epilepsy and bipolar disorder, not for alcohol use disorder.